Jiangsu Kanion Pharmaceutical Co. Ltd. Class ASSE: 600557

Report for Q1 2026

· Issued by Jiangsu Kanion Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange
Report for Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Earlier from Jiangsu Kanion Pharmaceutical Co. Ltd. Class A

All Jiangsu Kanion Pharmaceutical Co. Ltd. Class A news releases